First published: 01/08/2024
Flo Health, a leading women's health app, has secured over $200 million in Series C funding from investment firm General Atlantic, propelling the startup to a valuation exceeding $1 billion and achieving unicorn status. This milestone reflects Flo Health's growing influence in the digital health sector, particularly in women's health.
Flo Health offers a comprehensive tool for preventive care and health education, allowing users to track menstrual cycles, monitor over 70 symptoms, and access personalised health insights. The app's primary aim is to empower women with knowledge, enabling them to have informed discussions about their health and identify potential health issues early.
The new funding is set to drive Flo Health's expansion into new areas, including perimenopause and menopause. It will also enhance the app's capabilities, increase research and development personnel, and support strategic growth initiatives. Dmitry Gurski, co-founder and CEO of Flo Health, highlighted the company's ambitious goal of reaching one billion women globally through its pro-social program. This initiative provides free access to Flo Premium in 66 countries, including India, Indonesia, and Nigeria. "This investment from General Atlantic will help propel Flo Health’s growth as we continue normalising conversations about women’s health, improving health literacy, and raising awareness of women’s health issues worldwide, especially in underserved regions," Gurski stated.
The announcement has sparked discussions on LinkedIn regarding representation in the tech and health industries due to the fact it has been founded by men, led by men and funded by men, emphasising the importance of diverse perspectives in shaping products and services that cater to women's health needs.
Comments